Don't Miss The Burgeoning Lithium Megatrend
By 2025... manufacturers will need 1.1 million tons of lithium. Here's how investors could take advantage of this lithium explosion.
See The Full Report On The Lithium Explosion Now

EYEG Insider Trading (EyeGate Pharmaceuticals)

Insider Ownership Percentage: 58.20%
Insider Buying (Last 12 Months): $8,007,658.23
Insider Selling (Last 12 Months): $0.00

EyeGate Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at EyeGate Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

EyeGate Pharmaceuticals Share Price & Price History

Current Price: $3.16
Price Change: Price Decrease of -0.61 (-16.18%)
As of 07/28/2021 04:58 PM ET

This chart shows the closing price history over time for EYEG up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Next Plant-Based Unicorn
The plant-based industry has been ignited. Pay close attention to this stock.
Learn more.

EyeGate Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/6/2021Armistice Capital, LlcDirectorBuy1,531,101$5.23$8,007,658.23View SEC Filing Icon  
2/10/2020Armistice Capital Master FundMajor ShareholderBuy23,000$5.97$137,310.00
11/12/2019Morton GoldbergDirectorSell2,001$4.72$9,444.72
9/30/2019Armistice Capital Master FundMajor ShareholderBuy605,001$3.12$1,887,603.12
7/15/2019Brenda MannVPSell19,049$0.24$4,571.76View SEC Filing Icon  
7/15/2019Sarah RomanoCFOSell19,750$0.24$4,740.00View SEC Filing Icon  
7/15/2019Stephen FromInsiderSell127,355$0.24$30,565.20View SEC Filing Icon  
3/29/2019Armistice Capital Master FundMajor ShareholderBuy549,647$0.32$175,887.04View SEC Filing Icon  
12/11/2018Armistice Capital Master FundMajor ShareholderBuy100,353$0.40$40,141.20View SEC Filing Icon  
11/16/2018Armistice Capital Master FundMajor ShareholderBuy360,000$0.45$162,000.00View SEC Filing Icon  
See Full Table
Insider Selling at EyeGate Pharmaceuticals?
Sign-up to receive's daily insider buying and selling report for EyeGate Pharmaceuticals and related companies.

SEC Filings (Institutional Ownership Changes) for EyeGate Pharmaceuticals (NASDAQ:EYEG)

53.80% of EyeGate Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at EYEG by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

EyeGate Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/21/2021Citadel Advisors LLC20,177$100K0.0%N/A0.284%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC20,177$100K0.0%N/A0.284%Search for SEC Filing on Google Icon
5/17/2021Armistice Capital LLC3,346,601$16.67M0.4%+84.3%47.149%Search for SEC Filing on Google Icon
5/14/2021Parkman Healthcare Partners LLC75,295$0.38M0.1%N/A1.061%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC146,590$0.73M0.0%N/A2.065%Search for SEC Filing on Google Icon
2/20/2020Geode Capital Management LLC33,686$0.34M0.0%N/A0.832%Search for SEC Filing on Google Icon
2/13/2020Renaissance Technologies LLC32,796$0.33M0.0%N/A0.810%Search for SEC Filing on Google Icon
2/4/2020Virtu Financial LLC12,913$0.13M0.0%N/A0.319%Search for SEC Filing on Google Icon
8/16/2019Susquehanna International Group LLP222,297$53K0.0%N/A0.487%Search for SEC Filing on Google Icon
2/7/2019Acadian Asset Management LLC97,723$46K0.0%+28.5%0.225%Search for SEC Filing on Google Icon
1/16/2019Virtu Financial LLC68,391$32K0.0%+465.6%0.157%Search for SEC Filing on Google Icon
2/14/2018Armistice Capital LLC1,284,000$1.37M0.1%-20.5%7.465%Search for SEC Filing on Google Icon
9/27/2017Sabby Management LLC345,524$0.47M0.0%N/A2.008%Search for SEC Filing on Google Icon
8/15/2016Sabby Management LLC386,940$1M0.1%N/A4.636%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
EyeGate Pharmaceuticals logo
EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.
Read More on EyeGate Pharmaceuticals

Today's Range

Now: $3.16
Low: $3.15
High: $3.70

50 Day Range

MA: $4.03
Low: $3.12
High: $4.74

52 Week Range

Now: $3.16
Low: $3.10
High: $8.18


73,355 shs

Average Volume

467,223 shs

Market Capitalization

$22.43 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of EyeGate Pharmaceuticals?

EyeGate Pharmaceuticals' top insider investors include:
  1. Armistice Capital Master Fund (Major Shareholder)
  2. Armistice Capital, Llc (Director)
  3. Morton Goldberg (Director)
Three Cryptocurrencies to Hold in 2021
In 2021, Dogecoin went up over 12,000%. SafeMoon went up more than 20,000%...

But if you missed those gains, there is still time to get in on the digital currency boom.

Luke Lango – InvestorPlace’s resident crypto expert – just released the names of 3 tokens every investor should own in a free report.
Click here to claim your copy today.